<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ruf CG</submitter><funding>70112789</funding><pagination>2889-2900</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9712330</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(12)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Testicular germ cell tumours (GCTs) represent the most common malignancy in young adult males with two thirds of all cases presenting with clinical stage I (CSI). Active surveillance is the management modality mostly favoured by current guidelines. This systematic review assesses the treatment results in CSI patients concerning recurrence rate and overall survival in non-seminoma (NS) and pure seminoma (SE) resulting from surveillance in comparison to adjuvant strategies.&lt;h4>Methods/systematic review&lt;/h4>We performed a systematic literature review confining the search to most recent studies published 2010-2021 that reported direct comparisons of surveillance to adjuvant management. We searched Medline and the Cochrane Library with additional hand-searching of reference list</pubmed_abstract><journal>World journal of urology</journal><pubmed_title>Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review.</pubmed_title><pmcid>PMC9712330</pmcid><funding_grant_id>70112789</funding_grant_id><pubmed_authors>Oechsle K</pubmed_authors><pubmed_authors>Zengerling F</pubmed_authors><pubmed_authors>Lackner J</pubmed_authors><pubmed_authors>Busch J</pubmed_authors><pubmed_authors>Heinzelbecker J</pubmed_authors><pubmed_authors>Ruf CG</pubmed_authors><pubmed_authors>Dieckmann KP</pubmed_authors><pubmed_authors>Albers P</pubmed_authors><pubmed_authors>Winter C</pubmed_authors><pubmed_authors>Schmidt S</pubmed_authors><pubmed_authors>Krege S</pubmed_authors><pubmed_authors>Kliesch S</pubmed_authors><pubmed_authors>Oing C</pubmed_authors><pubmed_authors>Pfister D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review.</name><description>&lt;h4>Purpose&lt;/h4>Testicular germ cell tumours (GCTs) represent the most common malignancy in young adult males with two thirds of all cases presenting with clinical stage I (CSI). Active surveillance is the management modality mostly favoured by current guidelines. This systematic review assesses the treatment results in CSI patients concerning recurrence rate and overall survival in non-seminoma (NS) and pure seminoma (SE) resulting from surveillance in comparison to adjuvant strategies.&lt;h4>Methods/systematic review&lt;/h4>We performed a systematic literature review confining the search to most recent studies published 2010-2021 that reported direct comparisons of surveillance to adjuvant management. We searched Medline and the Cochrane Library with additional hand-searching of reference list</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-18T22:26:33.898Z</modification><creation>2025-04-07T10:09:49.205Z</creation></dates><accession>S-EPMC9712330</accession><cross_references><pubmed>36107211</pubmed><doi>10.1007/s00345-022-04145-6</doi></cross_references></HashMap>